DRG uses cookies to improve your experience on this website. Some of the cookies we use are essential for parts of the website to operate. Please be aware that if you continue without changing your cookie settings, you consent to this. For more information on our use of cookies, please review our cookie policy.

Market Assessment

Benefit from in-depth current and forward-looking analysis of diseases, therapies, and treatment landscapes within the biopharma market.


DRG’s Market Assessment solutions illuminate brand usage across different lines of therapy, identifying opportunities for increased market positions and highlighting unmet needs that can translate into commercial opportunities, enabling you to maximize market share.


• Gain insight into epidemiology covering 170+ indications, covering up to 45 countries and many subpopulations

• Understand disease-specific markets and therapies, including sales forecasts by branded or generic/biosimilar drug, class, and type

• Discover current and predicted treatment protocols, prescribing behaviors, and the detailed patient journey, for a wide range of indications

Contact us now to get started.


Get the answers you need with expert insights powered by primary market research, real world data, and disease-area expertise directly from within the Market Assessment Insights Platform.


Request more info

Get the full story of a disease through our Market Assessment solution portfolio

Unmet Need

Primary research and conjoint analysis with high-prescribing physicians to determine the most commercially viable unmet...